C2 Pharma to exhibit at CPhI Worldwide 2017

Published: 28-Sep-2017 Featured companies: C-squared Pharma
Manufacturing

C2 Pharma (formerly Centroflora CMS) is a Luxembourg-based pharmaceutical group established in 2014

C2 Pharma manufactures and distributes its active pharmaceutical ingredients and complex chemical compounds from phytochemical and chemical origins.

The current API product portfolio includes: atropine, digoxin, homatropine, pilocarpine, N-butylbromide scopolamine / hyoscine (SNBB) and reaches more than 100 pharmaceutical companies across the US, Western and Eastern Europe, South America, Asia, Africa and Australia.

Meet C2 Pharma at CPhI WW 2017; stand 11.0.B40

Featured companies

C2 PHARMA is an European pharmaceutical group established in 2014. It manufactures and distributes active pharmaceutical ingredients (APls) and complex chemical compounds...
See more

You may also like

Manufacturing

C2 PHARMA marks 10 years at CPHI Milan with expanded ophthalmic APIs

Read more
The complany is ready to showcase its expanding ophthalmic API portfolio and global regulatory filings, featuring Naphazoline Hydrochloride and Tropicamide

Trending Articles

  1. Reckitt expands US OTC manufacturing footprint with North Carolina facility The site in Wilson will be responsible for producing Mucinex® branded tablets and liquids, which are designed as over the counter (OTC) medicines for cold and flu symptoms
  2. Amgen invests $1bn into new US drug manufacturing facility The site will be the CDMO's second drug substance manufacturing facility in North Carolina, and will boost its presence in the US pharmaceutical market
  3. New Sicco desiccators and drying cabinets guide available now Flexible and robust solutions for drying and storage
  4. Thermo Fisher Scientific introduces CTS Detachable Dynabeads for cell therapy production New products enable precise T cell isolation, advancing CAR-T therapy development
  5. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company

Relevant companies

See more

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

C2 PHARMA marks 10 years at CPHI Milan with expanded ophthalmic APIs

The complany is ready to showcase its expanding ophthalmic API portfolio and global regulatory filings, featuring Naphazoline Hydrochloride and Tropicamide
Manufacturing

C2 Pharma focuses on ophthalmic APIs at CPHI

Located at stand 4D49, the company looks forward to informing customers about its expanded logistics facility in Frankfurt and what its unique DEV Pack approach can do to streamline API processes
Manufacturing

EDQM grants C2 Pharma CEP approval for commercial sale of cyclopentolate hydrochloride

The manufacturing process was documented by ASM in a development pack (dev-pack) and transferred to Indian manufacturing partners, Laurus Labs
Distribution

C2 Pharma reveals C-DMF approval of its API

This milestone comes after a challenging three-year journey, due to "global disruptions caused by the Covid pandemic"
Manufacturing

C2 Pharma's CEO Andrew Badrot on his journey with the company

"We think of our customers and their needs. If they need an API which is HPAPI, then we will explore that.”
Manufacturing

C2 Pharma expands API portfolio

Micronised Digoxin has been a particular focus of the expanded offerings with tech transfers and more new APIs in the pipeline
Manufacturing

API manufacturing success for C2 Pharma

C2 Pharma successfully completes validation campaigns for digoxin and digoxin micron
Subscribe now